Genesis Medtech Group Raises Significant Growth Investment In Latest Round Of Series B Financing
May 24, 2021•about 4 years ago
Round Type
series b
Description
Genesis MedTech Group ("Genesis"), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors.
FundzWatch™ Score
88
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood